Phase I, open-label, parallel-group volunteer study to assess the pharmacokinetics and safety of SKY0402 in subjects with impaired hepatic function.

Trial Profile

Phase I, open-label, parallel-group volunteer study to assess the pharmacokinetics and safety of SKY0402 in subjects with impaired hepatic function.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Mar 2011

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Mar 2011 Results reported at the 112th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in March 2011, according to a Pacira Pharmaceuticals media release.
    • 16 Jun 2009 Primary outcome amended as reported by ClinicalTrials.gov
    • 16 Jun 2009 Planned end date changed from 1 Apr 2009 to 1 Aug 2009 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top